Tag Dechra

Dechra Osurnia Update

Dechra’s OSURNIA® (florfenicol-terbinafine-betamethasone acetate) will be transitioning to a new Dechra trade dress.  The new label will provide the same product you are familiar with, in our Dechra brand and trade dress.   There will be no change in the NDC/item numbers, pricing, and…

Mirataz Exp Extension

Attached is a letter from Jan Cunningham, Dechra’s Director of Regulatory Affairs, North America, explaining the Mirataz®(mirtazapine transdermal ointment) shelf life extension, from 30 months to 48 months, which was approved by FDA in October 2019. The letter includes information…